TF and venous thromboembolism: As this phenomenon can be observed in vitro by using isolated EVs from tumor cell lines and adding plasmatic coagulation factors, clinical studies aim at correlating tissue factor-positive EVs (TF+EVs) with clinical events such as venous thromboembolism (VTE) (Geddings and Mackman 2013).